Mr. Escobar is the Chief Executive Officer for the MT Venom corporation, a successful veterinary biologics company in the United States. With more than 30 years of practical education and experience as a skilled veterinary technician, Walter launched his start-up corporation and introduced Venom Vet, the only USDA-approved F[ab’]2 antivenom in the North American veterinary market, in 2014. MT Venom is also currently completing clinical trials in Australia for its VenomVet Australia antivenom, with plans to introduce this product into the Australian market. Mr. Escobar has been fully engaged in the permitting process for these products, including initial submissions, study designs, identification of study participants, Outlines of Production, protocols and final study report submissions, labeling and packaging, international shipping and storage, marketing and distribution, and maintenance of permit requirements.